CPH:CC News and Press, Cipher Pharmaceuticals Inc. From 09/05/23

Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian Dollars Canada NewsWire MISSISSAUGA, ON , Sept. 5, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or " the Co...

Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in Mexico Canada NewsWire (All figures are presented in U.S. dollars) Strong growth capital available with $36.3 million in cash and cash equivalents Net income increased by 32% y...

Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , July 28, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced that it will release its financial ...

Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European Union Canada NewsWire Significant regulatory milestone reached by Moberg, paving the way for their commercial launch across 13 countries in Europe Cipher holds exclusive Canadian ri...

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON , June 21, 2023 /CNW/ - Cipher Pharmaceuticals Inc . (TSX: CPH) (" Cipher " or the "Company ") today announced that it held its annu...

Cipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial Flexibility Canada NewsWire (All figures are presented in U.S. dollars) Cash on hand grew by $4.6 million to $33.4 million EPS increased 25...

Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , May 4, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced that it will release its financial re...

Mississauga, Ontario--(Newsfile Corp. - April 18, 2023) - Cipher Pharmaceuticals (TSX: CPH), a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, w...

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results Canada NewsWire (All figures are in U.S. dollars) Product revenue increased 9% to $12.5 million in 2022 EBITDA of $12.0 million , relatively flat YoY Cash at ...

Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , March 10, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced that it will release its fina...